Lanreotide for the Treatment of Neuroendocrine Tumours: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet].

This review aims to summarize evidence regarding the clinical and cost-effectiveness, as well as guidelines for the use of lanreotide autogel in the treatment of neuroendocrine tumors (NETs) in adult patients.

https://ift.tt/2N1XTtj